They are a newly incorporated blank check company. They intend to capitalize on the ability of their management team to identify, acquire and operate a business at the intersection of the healthcare and technology industries. Their management team and board of directors will be led by Peter Hébert, their Chairman. Josh DeFonzo will serve as their Chief Executive Officer, and a member of their board of directors. Segolene Scarborough will serve as their Chief Financial Officer and Treasurer. They expect Dr. Bijan Salehizadeh, Senator Joseph Robert "Bob" Kerrey and Dr. Fred Moll to join their board of directors at the closing of this offering. Mr. Peter Hébert is a co-founder and managing partner of Lux and oversees Lux’s investments at the intersection of technology and medical devices, including Auris Health, which was acquired by Johnson & Johnson, and Avail Medsystems. Mr. Josh DeFonzo is a former President at Johnson & Johnson (Robotics & Digital Solutions), the former Chief Operating Officer of Auris Health, and a former Chief Commercial Officer of CareDx (Nasdaq: CDNA).